Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R129756-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $136.90 | |
R129756-100mg | 100mg | In stock | $492.90 | |
R129756-500mg | 500mg | In stock | $2,216.90 | |
R129756-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $3,989.90 | |
R129756-5g | 5g | In stock | $17,950.90 | |
R129756-10g | 10g | In stock | $32,311.90 |
Potent, selective PPARγ agonist. Maleate salt.
Synonyms | Rosiglitazone maleate | 155141-29-0 | Avandia | Rosiglitazone XR | Rosiglitazone (maleate) | Rosiglitazone Maleate [USAN] | BRL-49653C | BRL 49653C | Rosiglitzazone maleate | BRL-49653-C | NSC-717764 | UNII-KX2339DP44 | 5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidi |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | Potent, selective PPARγ agonist (EC 50 = 43 nM). Maleate salt. Improves adipocyte function, restores insulin sensitivity, and inhibits atherosclerosis in vivo . Orally active. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Action Type | AGONIST |
Mechanism of action | Peroxisome proliferator-activated receptor gamma agonist |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (Z)-but-2-enedioic acid;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
---|---|
INCHI | InChI=1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1- |
InChi Key | SUFUKZSWUHZXAV-BTJKTKAUSA-N |
Canonical SMILES | CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O |
Isomeric SMILES | CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=C\C(=O)O)\C(=O)O |
PubChem CID | 5281055 |
Molecular Weight | 473.5 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2217131 | Certificate of Analysis | May 10, 2024 | R129756 |
F2220022 | Certificate of Analysis | Apr 02, 2024 | R129756 |
F2220021 | Certificate of Analysis | Apr 02, 2024 | R129756 |
F2220020 | Certificate of Analysis | Apr 02, 2024 | R129756 |
E2217143 | Certificate of Analysis | Mar 14, 2024 | R129756 |
E2217152 | Certificate of Analysis | Mar 14, 2024 | R129756 |
Solubility | DMSO 95 mg/mL Water Ethanol 2 mg/mL |
---|
Pictogram(s) | GHS08, GHS09, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H411:Toxic to aquatic life with long lasting effects H302:Harmful if swallowed H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P391:Collect spillage. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
1. Kraakman MJ et al.. (2018) PPAR? deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects.. J Clin Invest, 128 (6): (2600-2612). [PMID:29589839] |
2. Aaron N et al.. (2021) Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells.. Elife, 10 [PMID:34155972] |
3. Chan M et al.. (2019) Identification of a natural beige adipose depot in mice.. J Biol Chem, 294 (17): (6751-6761). [PMID:30824545] |
4. Liu L et al.. (2020) PPAR? Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment.. Diabetes, 69 (8): (1793-1803). [PMID:32409492] |